Kang‐Yell Choi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Bone anabolic agents promoting bone formation and rebuilding damaged bones would ideally overcome the limitations of anti-resorptive therapy, the current standard prescription for osteoporosis. However, the currently prescribed parathyroid hormone (PTH)-based anabolic drugs present limitations and adverse effects including osteosarcoma during long-term use.(More)
  • 1